Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

DD

Analyzing the Factors Behind DD's Stock Plunge

DuPont de Nemours stock is trading -21.54% below its average target price of $85.07 after dropping -2.7% during today's afternoon session. Analysts are giving the Large-Cap Chemicals company an average rating of buy and target prices ranging from $47.0 to $113.0 per share.

DuPont de Nemours's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.3%. The stock's short ratio is 1.45. The company's insiders own 0.21% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 73.2%. In conclusion, we believe there is mixed market sentiment regarding DuPont de Nemours.

Institutions Invested in DuPont de Nemours

Date Reported Holder Percentage Shares Value
2025-03-31 Vanguard Group Inc 11% 46,894,623 $3,130,216,085
2025-03-31 Blackrock Inc. 8% 33,421,736 $2,230,900,878
2025-03-31 State Street Corporation 4% 17,521,123 $1,169,534,960
2025-03-31 Massachusetts Financial Services Co. 3% 11,472,260 $765,773,355
2025-03-31 Geode Capital Management, LLC 2% 10,286,069 $686,595,105
2025-03-31 Nuveen, LLC 2% 7,110,827 $474,647,702
2025-03-31 Franklin Resources, Inc. 2% 7,111,200 $474,672,600
2025-03-31 Invesco Ltd. 2% 7,026,628 $469,027,419
2025-03-31 Morgan Stanley 2% 7,001,275 $467,335,106
2025-03-31 Northern Trust Corporation 1% 4,694,843 $313,380,770
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS